The Risk Authority, Stanford Health Care

 Intercell's Transcutaneous vaccination system

Future Medical Systems collaborated with The Risk Authority (TRA) at Stanford Health Care to establish The Innovence Lab, a unique innovation team hosted at The Risk Authority, taking the issue of improving medication safety as a first case study.

A series of observations and interviews across the network uncovered new opportunities to systemically address medication administration safety. Ideation inspired by this insight generated 4 new systemic concepts, repeatedly involving front-line staff in co-creation and concept feedback sessions.

One outcome is the successful pilot and planned 2017 launch of the 'Medstime' concept in Lucile Packard Children's Hospital. This is a system of nursing practice that empowers parents and family to engage in medication safety processes while reducing distraction and supporting the nurse's workflow.

Johnson & Johnson

 J&J's team are implementing a behaviorial management system to ensure patient's (and parent's) experiences are optimal, leading to better outcomes

A subsidiary of Johnson & Johnson developed a novel approach to an in-office pediatric ENT procedure.

The team worked with their marketing and development teams to define a system approach to maximize the safety and efficacy of the treatment. This included qualitative research with parents, ENT surgeons, nurses and child development experts.

In addition to defining a complete system of 'props' to keep infants calm and still, we created training guides for nurses and take-home informative storybooks for parents to inform their children (and themselves) about the procedure they were about to undergo.

Eli Lilly

 LIlly recently launched a new self-injection device to deliver next generation protein therapies to treat diabetes

In bringing the next generation of monoclonal antibody (mAb) therapies to market, Eli Lilly wanted to deliver a best-in-class drug delivery experience, while staking out a technology platform in a crowded IP space.

The design team started by understanding the real needs and struggles of patients and caregivers in the target market: what features would both differentiate a new device and make it easier to use?

Guided by this insight, the team invented an unprecedentedly simple and intuitive interface. In a study, 94% of people said the Trulicity pen was easy to use.